Federal University of Ceara   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Fortaleza Portugal (1954)

Organization Overview

First Clinical Trial
2005
NCT00612469
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC) | Federal Institute of Science and Technology of Ceara | Federal University of Ceará (UFC), Brazil. | Federal University of Ceara - UNIFAC | Núcleo de Pesquisa e Desenvolvimento de Medicamentos | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | Universidade Federal do Ceara | Universidade Federal do Ceará | Universidade Federal do Ceara (UFC)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 3)

Constipation (Phase 3)

Dental Pulp Necrosis (Phase 2)

Depression (Phase 3)

Diarrhea (Phase 3)

Disease (Phase 3)

Inflammation (Phase 3)

Intestinal Diseases (Phase 3)

Malnutrition (Phase 3)

Movement Disorders (Phase 3)

Necrosis (Phase 2)

Schizophrenia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 17
  • # of Trial APIs: 21